Document is current
Any future updates will be listed below
-
Authors
Meng, Ying https://orcid.org/0000-0002-1165-9009
Guo, Dong
Lin, Liming
Zhao, Hong
Xu, Weiting
Luo, Shudi
Jiang, Xiaoming
Li, Shan
He, Xuxiao
Zhu, Rongxuan
Shi, Rongkai
Xiao, Liwei https://orcid.org/0000-0001-6971-9222
Wu, Qingang
He, Haiyan
Tao, Jingjing https://orcid.org/0000-0001-6473-3797
Jiang, Hongfei
Wang, Zheng
Yao, Pengbo https://orcid.org/0000-0003-2091-7142
Xu, Daqian https://orcid.org/0000-0003-0478-2997
Lu, Zhimin https://orcid.org/0000-0002-2859-2736
- License Information
-
More Information
Article History
Received: 27 February 2023
Accepted: 10 April 2024
First Online: 21 May 2024
Competing interests
: Z.L. owns shares in Signalway Biotechnology, which supplied the rabbit antibodies that recognize PFKL pT331 and PLIN2 pS159. Z.L.’s interest in this company had no bearing on it being chosen to supply these reagents. The remaining authors declare no competing interests.
